Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4102)
All Articles published online
|
Apr 21, 2010 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16(15): 1832-1836 [PMID: 20397259 DOI: 10.3748/wjg.v16.i15.1832] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1832.htm |
| Number | Citing Articles |
| 1 |
James Sligh, Jaroslav Janda, Jana Jandova. Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2014; 769: 49 doi: 10.1016/j.mrfmmm.2014.07.003
|
| 2 |
Yin Xia, Linlin Zhou, Hung-Chih Yang, Chen-Wei Yu. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance. International Immunopharmacology 2022; 113: 109372 doi: 10.1016/j.intimp.2022.109372
|
| 3 |
Antonio Solinas, Diego F Calvisi. Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas. World Journal of Gastroenterology 2015; 21(12): 3472-3479 doi: 10.3748/wjg.v21.i12.3472
|
| 4 |
Lorenzo A. Orci, Stéphanie Lacotte, Graziano Oldani, Philippe Morel, Gilles Mentha, Christian Toso. The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence. Digestive Diseases and Sciences 2014; 59(9): 2058 doi: 10.1007/s10620-014-3182-7
|
| 5 |
Carmen Berasain, María Ujue Latasa, Raquel Urtasun, Saioa Goñi, María Elizalde, Oihane Garcia-Irigoyen, María Azcona, Jesús Prieto, Matías A. Ávila. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers 2011; 3(2): 2444 doi: 10.3390/cancers3022444
|
| 6 |
Olaia Martínez-Iglesias, Elvira Alonso-Merino, Ana Aranda. Tumor suppressive actions of the nuclear receptor corepressor 1. Pharmacological Research 2016; 108: 75 doi: 10.1016/j.phrs.2016.04.027
|
| 7 |
Wan Liu, Wenjing Wang, Xinran Wang, Cong Xu, Ning Zhang, Wen Di. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Cancer Letters 2020; 472: 59 doi: 10.1016/j.canlet.2019.12.024
|
| 8 |
Anupam Bishayee. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
|
| 9 |
Jakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska, Paweł Knapp. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer. Molecules 2022; 27(7): 2041 doi: 10.3390/molecules27072041
|
| 10 |
Junwei Han, Siyao Liu, Yunpeng Zhang, Yanjun Xu, Ying Jiang, Chunlong Zhang, Chunquan Li, Xia Li. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs. Oncotarget 2016; 7(34): 55012 doi: 10.18632/oncotarget.10839
|
| 11 |
Yidi Sun. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1). Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1183795
|
| 12 |
Burcu Sengez, Brian I. Carr, Hani Alotaibi. EMT and Inflammation: Crossroads in HCC. Journal of Gastrointestinal Cancer 2023; 54(1): 204 doi: 10.1007/s12029-021-00801-z
|
| 13 |
Xinjie Lu. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1
in Cancer. Current Medicinal Chemistry 2022; 29(41): 6228 doi: 10.2174/0929867329666220629140540
|
| 14 |
Ke‐qi Han, Hui Han, Xue‐qun He, Lei Wang, Xiao‐dong Guo, Xue‐ming Zhang, Jie Chen, Quan‐gang Zhu, Hua Nian, Xiao‐feng Zhai, Ma‐wei Jiang. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma. Cancer Medicine 2016; 5(10): 2861 doi: 10.1002/cam4.843
|
| 15 |
Zhitao Zhou, Xiao Lu, Ping Zhu, Wei Zhu, Xia Mu, Rongmei Qu, Ming Li. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Biochemical and Biophysical Research Communications 2012; 420(2): 336 doi: 10.1016/j.bbrc.2012.02.160
|
| 16 |
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
|
| 17 |
Hacer Sahin, Christian Trautwein, Hermann E. Wasmuth. Functional role of chemokines in liver disease models. Nature Reviews Gastroenterology & Hepatology 2010; 7(12): 682 doi: 10.1038/nrgastro.2010.168
|
| 18 |
QUANCHI CHEN, WEI SUN, YUXIN LIAO, HUI ZENG, LIANCHENG SHAN, FEI YIN, ZHUOYING WANG, ZIFEI ZHOU, YINGQI HUA, ZHENGDONG CAI. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT. Molecular Medicine Reports 2015; 12(1): 219 doi: 10.3892/mmr.2015.3375
|
| 19 |
Chunyan Li, Dong Kang, Xiguang Sun, Yufei Liu, Jinhong Wang, Pujun Gao. The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/345413
|
| 20 |
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells. Nutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
|
| 21 |
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Journal of Histochemistry & Cytochemistry 2019; 67(5): 299 doi: 10.1369/0022155418824274
|
| 22 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 23 |
Wen‐Hsiu Hsu, Cheng‐Nan Chen, Hai‐I Huang, Yi‐Liang Lai, Chun‐Yuh Teng, Wu‐Hsien Kuo. Urokinase induces stromal cell‐derived factor‐1 expression in human hepatocellular carcinoma cells. Journal of Cellular Physiology 2012; 227(2): 697 doi: 10.1002/jcp.22777
|
| 24 |
Qiaofei Liu, Aiqun Zhang, Wenli Xu, Jiahong Dong. A new view of the roles of blood flow dynamics and Kupffer cell in intra-hepatic metastasis of hepatocellular carcinoma. Medical Hypotheses 2011; 77(1): 87 doi: 10.1016/j.mehy.2011.03.033
|
| 25 |
Christian Breunig, Bernadett J. Mueller, Ludmila Umansky, Kristin Wahl, Katrin Hoffmann, Frank Lehner, Michael P. Manns, Heike Bantel, Christine S. Falk. BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma. Clinical Cancer Research 2014; 20(9): 2410 doi: 10.1158/1078-0432.CCR-13-1635
|
| 26 |
Justin Monnier, Mathieu Boissan, Annie L’Helgoualc’h, Marie-Lise Lacombe, Bruno Turlin, Jessica Zucman-Rossi, Nathalie Théret, Claire Piquet-Pellorce, Michel Samson. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. European Journal of Cancer 2012; 48(1): 138 doi: 10.1016/j.ejca.2011.06.044
|
| 27 |
Jialiang Wang, Xiaoyu Zhang, Xinyi Ma, Dongmei Chen, Meina Cai, Lexin Xiao, Jing Li, Zexuan Huang, Yuehua Huang, Yifan Lian. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02885-w
|
| 28 |
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. Medical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
|
| 29 |
Gang Han, Dawei Wu, Yongan Yang, Zhiyun Li, Jiapin Zhang, Chengjun Li. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer. Cytokine 2015; 76(2): 163 doi: 10.1016/j.cyto.2015.05.009
|
| 30 |
Marie Anson, Anne-Marie Crain-Denoyelle, Véronique Baud, Fanny Chereau, Angélique Gougelet, Benoit Terris, Satoshi Yamagoe, Sabine Colnot, Mireille Viguier, Christine Perret, Jean-Pierre Couty. Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. Journal of Clinical Investigation 2012; 122(2): 586 doi: 10.1172/JCI43937
|
| 31 |
Olaia A. Martínez-Iglesias, Elvira Alonso-Merino, Sara Gómez-Rey, Juan Pedro Velasco-Martín, Rosa Martín Orozco, Enrique Luengo, Rosa García Martín, Inmaculada Ibáñez de Cáceres, Agustín F. Fernández, Mario F. Fraga, Pilar González-Peramato, Constantino Varona, José Palacios, Javier Regadera, Ana Aranda. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis. Proceedings of the National Academy of Sciences 2016; 113(3) doi: 10.1073/pnas.1520469113
|
| 32 |
AW Wahid Ansari, Reinhold E Schmidt, Esaki M Shankar, Adeeba Kamarulzaman. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0341-8
|
| 33 |
Bosheng He, Ying He, Weixiang Shi, Shenchu Gong, Xiaohong Chen, Jing Xiao, Jinhua Gu, Wenbin Ding, Yilang Wang. Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma. Molecular Medicine Reports 2017; 15(6): 3681 doi: 10.3892/mmr.2017.6445
|
| 34 |
S. Costantini, G. Di Bernardo, M. Cammarota, G. Castello, G. Colonna. Gene expression signature of human HepG2 cell line. Gene 2013; 518(2): 335 doi: 10.1016/j.gene.2012.12.106
|
| 35 |
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
|
| 36 |
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1): 25 doi: 10.1038/cmi.2013.37
|
| 37 |
Maria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, Nunzia Simona Losito, Maria Napolitano, Luigi Portella, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Trotta, Steven Curley, Susan Costantini, Raffaele Liuzzi, Francesco Izzo, Stefania Scala. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not. Cellular & Molecular Immunology 2015; 12(4): 474 doi: 10.1038/cmi.2014.102
|
| 38 |
Xiao-Lan Wei, Jing Zhang, Zhi-Hong Mo. Regulation of chemokine receptor CXCR4 in HepG2 cell adhesion sensing by QCM. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 1317 doi: 10.1109/HHBE.2011.6029075
|
| 39 |
Siti A Sulaiman, Nadiah Abu, Nurul-Syakima Ab-Mutalib, Teck Yew Low, Rahman Jamal. Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion. Future Oncology 2019; 15(22): 2603 doi: 10.2217/fon-2018-0909
|
| 40 |
Christian Stock. From Malignant Transformation to Metastasis. Reviews of Physiology, Biochemistry and Pharmacology 2021; 182: 139 doi: 10.1007/112_2021_68
|
| 41 |
Chang-Xian Li, Kwan Man, Chung-Mau Lo. The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation. Transplantation 2017; 101(11): 2665 doi: 10.1097/TP.0000000000001844
|
| 42 |
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, Ayana. R. Kumar, Benjamin S. Meyer, Arun Valsan, Vinod Vijayakurup, Lekshmi R. Nath. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma. Molecular Biotechnology 2023; doi: 10.1007/s12033-023-00890-0
|
| 43 |
Sen-Sen LIN, Fang-Fang LI, Li SUN, Wei FAN, Ming GU, Lu-Yong ZHANG, Song QIN, Sheng-Tao YUAN. Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAK. Chinese Journal of Natural Medicines 2016; 14(3): 203 doi: 10.1016/S1875-5364(16)30017-6
|
| 44 |
Kanjoormana Aryan Manu, Muthu K. Shanmugam, Tina H. Ong, Aruljothi Subramaniam, Kodappully Sivaraman Siveen, Ekambaram Perumal, Ramar Perumal Samy, Pradeep Bist, Lina H. K. Lim, Alan Prem Kumar, Kam M. Hui, Gautam Sethi, Kwan Man. Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma. PLoS ONE 2013; 8(3): e57015 doi: 10.1371/journal.pone.0057015
|
| 45 |
Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien‐jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei‐Hsuan Lee, Hwai‐I Yang. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individuals. Alimentary Pharmacology & Therapeutics 2021; 54(6): 833 doi: 10.1111/apt.16524
|
| 46 |
Weilong Chen, Yuanyuan Qin, Suling Liu. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1231: 53 doi: 10.1007/978-3-030-36667-4_6
|
| 47 |
Ken Shirabe, Takashi Motomura, Jun Muto, Takeo Toshima, Rumi Matono, Yohei Mano, Kazuki Takeishi, Hideki Ijichi, Noboru Harada, Hideaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Yoshihiko Maehara. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management. International Journal of Clinical Oncology 2010; 15(6): 552 doi: 10.1007/s10147-010-0131-0
|
| 48 |
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/684802
|
| 49 |
Yasuteru Kondo, Osamu Kimura, Yasuhito Tanaka, Masashi Ninomiya, Tomoaki Iwata, Takayuki Kogure, Jun Inoue, Masaya Sugiyama, Tatsuki Morosawa, Yasuyuki Fujisaka, Tooru Shimosegawa, J.-H. J. Ou.
Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1
+
Immune Cells
. Journal of Virology 2015; 89(14): 7016 doi: 10.1128/JVI.00716-15
|
| 50 |
Feng Xue, Brandon W. Higgs, Jiaqi Huang, Chris Morehouse, Wei Zhu, Xin Yao, Philip Brohawn, Zhan Xiao, Yinong Sebastian, Zheng Liu, Yun Xia, Dong Shen, Mike Kuziora, Zhengwei Dong, Hulin Han, Yi Gu, Jianren Gu, Qiang Xia, Yihong Yao. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0743-2
|
| 51 |
Li Li, Jing Yan, Jing Xu, Chao-Qun Liu, Zuo-Jun Zhen, Huan-Wei Chen, Yong Ji, Zhi-Peng Wu, Jian-Yuan Hu, Limin Zheng, Wan Yee Lau, Cordula M. Stover. CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma. PLoS ONE 2014; 9(10): e110064 doi: 10.1371/journal.pone.0110064
|
| 52 |
Hiroshi Miyazaki, Kazuaki Takabe, W Andrew Yeudall. Chemokines, chemokine receptors and the gastrointestinal system. World Journal of Gastroenterology 2013; 19(19): 2847-2863 doi: 10.3748/wjg.v19.i19.2847
|
| 53 |
Ho-Sung Lee, In-Hee Lee, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee, Bashar Saad. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5765233
|
| 54 |
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. The CCL20-CCR6 Axis in Cancer Progression. International Journal of Molecular Sciences 2020; 21(15): 5186 doi: 10.3390/ijms21155186
|
| 55 |
Chiara Taibi, Laura Vincenzi, Gianpiero D’Offizi. Hepatocellular Carcinoma. Updates in Surgery 2023; : 19 doi: 10.1007/978-3-031-09371-5_3
|
| 56 |
Rim Serhal, George Hilal, George Boutros, Joseph Sidaoui, Layal Wardi, Salah Ezzeddine, Nada Alaaeddine. Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/850246
|